| General Information of Drug Metabolite (DM) (ID: DM019699) |
| DM Name |
BLZ-945 M10
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2C8 (CYP2C8)
|
DME0018
|
| Unclear - Unclear |
BLZ-945
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| BLZ-945 |
DR3302
|
Phase 2 |
Amyotrophic lateral sclerosis |
|
|
| References |
| 1 |
Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
